TTK Healthcare Ltd

TTK Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

TTK Healthcare Ltd

₹ 1,445 -2.04%
21 Nov 4:00 p.m.
ttkhealthcare.com BSE: 507747 NSE: TTKHLTCARE
About

TTK Healthcare Ltd is engaged in the business of Pharmaceuticals, Consumer Products, Medical Devices, Protective Devices and Foods. [1]
It is a part of TT Krishnamachari group; whose flagship company, TTK Prestige Ltd is one of the leading kitchen appliances company in India.[2]

Key Points

Business Segments FY24
1. Consumer Products (~31% revenue, 29% Op. profit): The company markets and distributes products that transcend categories; baby care (Woodward’s Gripe Water), personal care (Eva Deodrants), home care- room & air fresheners (Good Home ), and sexual wellness (Skore).. [1] The Woodward's Gripe Water is one of the oldest FMCG brands worldwide and is a market leader in the Indian colic market. It has been marketed in India since 1928. It has a distribution network of 27 warehouses, 2,600+ distributors, 650+ frontline sales teams, and a reach of ~4 lakh outlets across India. [2]

Website BSE NSE
  • Market Cap ₹ 2,028 Cr.
  • Current Price ₹ 1,445
  • High / Low ₹ 1,923 / 1,232
  • Stock P/E 31.4
  • Book Value ₹ 735
  • Dividend Yield 0.69 %
  • ROCE 8.67 %
  • ROE 6.43 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 38.4%
  • Company has been maintaining a healthy dividend payout of 19.6%

Cons

  • Earnings include an other income of Rs.86.5 Cr.
  • Working capital days have increased from 21.5 days to 62.3 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Diversified Industry: Diversified - Medium / Small

Part of BSE Allcap BSE Industrials BSE SmallCap

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
150 159 159 193 170 183 180 202 186 184 181 208 198
148 150 154 189 166 174 165 192 176 179 169 201 190
Operating Profit 3 8 5 4 4 8 15 10 10 5 12 7 8
OPM % 2% 5% 3% 2% 2% 5% 8% 5% 5% 3% 7% 3% 4%
15 10 12 606 13 12 12 15 16 16 16 37 18
Interest 0 1 1 3 1 1 1 1 1 0 1 1 1
Depreciation 3 3 3 3 3 3 3 3 3 3 3 2 2
Profit before tax 14 14 12 604 13 16 23 21 22 18 24 41 23
Tax % 7% 15% 13% 1% 23% 26% 27% 24% 26% 27% 25% 23% 26%
13 12 11 601 10 12 17 16 16 13 18 32 17
EPS in Rs 9.07 8.61 7.52 425.23 7.01 8.49 11.99 11.09 11.33 9.12 12.93 22.35 12.17
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
382 416 483 519 528 578 628 646 476 599 725 753 771
362 396 453 478 489 535 578 617 457 577 694 715 738
Operating Profit 20 20 30 40 38 43 50 28 19 22 31 37 33
OPM % 5% 5% 6% 8% 7% 7% 8% 4% 4% 4% 4% 5% 4%
7 6 7 6 6 8 8 9 28 42 643 63 86
Interest 3 3 4 3 3 5 3 3 2 3 5 3 3
Depreciation 3 3 6 7 12 15 15 14 13 13 13 13 11
Profit before tax 22 20 26 36 29 30 39 19 32 48 657 84 106
Tax % 34% 37% 39% 36% 36% 40% 38% 37% -44% 13% 3% 25%
14 12 16 23 19 18 24 12 46 42 640 63 80
EPS in Rs 18.28 15.95 20.81 29.19 24.13 12.86 17.25 8.72 32.87 29.43 452.72 44.47 56.57
Dividend Payout % 22% 25% 22% 17% 21% 39% 29% 34% 18% 34% 2% 22%
Compounded Sales Growth
10 Years: 6%
5 Years: 4%
3 Years: 17%
TTM: 3%
Compounded Profit Growth
10 Years: 18%
5 Years: 21%
3 Years: 16%
TTM: 1%
Stock Price CAGR
10 Years: 6%
5 Years: 21%
3 Years: 31%
1 Year: 11%
Return on Equity
10 Years: 27%
5 Years: 32%
3 Years: 38%
Last Year: 6%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 8 8 8 8 8 14 14 14 14 14 14 14 14
Reserves 90 99 110 128 150 219 237 235 281 316 939 987 1,025
22 32 42 38 23 47 29 30 19 22 27 23 31
89 102 115 128 104 127 136 152 180 207 189 177 197
Total Liabilities 209 240 275 303 285 407 416 431 494 559 1,170 1,201 1,267
43 54 52 106 99 110 98 89 85 80 71 75 74
CWIP 0 2 46 1 0 1 2 9 0 0 3 1 5
Investments 1 0 0 10 9 9 13 9 13 15 13 13 16
165 184 177 185 177 288 304 325 395 463 1,083 1,112 1,171
Total Assets 209 240 275 303 285 407 416 431 494 559 1,170 1,201 1,267

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
24 13 39 37 18 25 17 20 96 45 -25 -5
-1 -15 -49 -27 5 -22 10 -13 -77 -30 32 28
-2 2 3 -11 -23 -7 -31 -10 -17 -10 -12 -22
Net Cash Flow 22 0 -7 -0 0 -4 -4 -4 2 5 -6 2

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 34 34 34 33 24 35 47 43 46 33 46 42
Inventory Days 52 64 62 66 65 80 77 101 123 102 89 105
Days Payable 55 56 50 53 100 130 101 121 170 134 116 110
Cash Conversion Cycle 31 41 46 46 -11 -16 22 23 -2 1 19 36
Working Capital Days -8 -12 -14 -22 -9 -1 10 13 -18 -15 17 62
ROCE % 21% 17% 20% 23% 18% 15% 15% 8% 6% 8% 10% 9%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
74.56% 74.56% 74.56% 74.57% 74.57% 74.57% 74.57% 74.57% 74.57% 74.57% 74.57% 74.57%
2.35% 2.40% 2.34% 2.37% 2.32% 2.38% 2.40% 1.85% 1.85% 1.85% 1.87% 1.90%
2.23% 2.40% 2.51% 2.22% 2.18% 2.99% 3.27% 3.23% 3.13% 1.14% 1.14% 1.14%
20.85% 20.64% 20.59% 20.84% 20.95% 20.07% 19.76% 20.37% 20.46% 22.45% 22.44% 22.39%
No. of Shareholders 16,41615,81715,22814,61714,99515,81816,10915,67216,65117,22116,93015,762

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls

  • Sep 2016
    Transcript
    Notes
    PPT